FDA approves drug that slows early Alzheimer's disease
In a clinical trial with 1,00 participants, researchers found Lecanemab can slow cognitive decline in Alzheimer's patients by 27%, effectively delaying the disease by about five months. a href=“https://www.cbsnews.com/texas/news/alzheimers-disease-drug-medication-fda-approves-lecanemab-leqembi/”Click here for more./a